Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
about
Antifungal and immunomodulating activities of 1,4-benzothiazine azole derivatives: review.Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection.A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cellsImmunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infectionsImmunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.Effects of antifungal agents on the function of human neutrophils in vitro.Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of miceComparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritisA model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice.Evidence for macrophage-mediated protection against lethal Candida albicans infection.Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection.
P2860
Q32100806-347080F3-DA66-4950-B006-93487F687381Q33559838-75ADD056-77F6-4839-9267-FE223784B8ECQ33977602-A3F16C9C-9353-4373-B5B8-A929F52ECC4EQ33978613-B7FA3C73-5F1A-4E31-B8BE-949522DFAE1DQ35165825-6E132D07-5452-44E1-911A-66DC7DC1B9CBQ35247865-740ED231-3AFE-4C79-9D88-16916C1FBD37Q35544061-C5370B3E-0289-4A87-A7B2-B97CC48CF587Q37012651-8AE5D447-2AC0-4AAA-9ACA-1FF4220968DBQ39814888-3BB95D4F-F09B-42FA-A35D-F7F594B99FC9Q39850531-F7AED7DD-B18B-4BBA-BE56-EA7B904B34A6Q40154273-5F01DD9E-9438-4EBB-93DA-29889FD8092FQ40172496-9C71D6AF-6EAE-485A-8383-B0EE2DAC7A5DQ40284723-A146C1E7-52E1-4D70-A56D-71D2BCD64E8AQ44027432-0FA02398-74F8-4878-B04D-6F2ADA85BB14Q54372357-D43F7D76-309E-4B6D-82AE-2D38178A1EF7
P2860
Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@ast
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@en
type
label
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@ast
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@en
prefLabel
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@ast
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@en
P2093
P2860
P356
P1476
Immunoadjuvant activity of amp ...... nfected with Candida albicans.
@en
P2093
Mazzolla R
Puccetti P
Vecchiarelli A
P2860
P304
P356
10.1128/AAC.27.4.625
P407
P577
1985-04-01T00:00:00Z